26
May
May
SKYCovion, the COVID-19 vaccine developed by SK Chemical compounds, has immediately been licensed by the Medicines and Healthcare merchandise Regulatory Company (MHRA). It turns into the eighth COVID-19 vaccine licensed by the UK’s unbiased medicines regulator. The authorization follows recommendation obtained from the unbiased Fee on Human Medicines (CHM). The SKYCovion vaccine combines part of […]
